Technology

The companies' $2.1 billion deal was announced in late 2019, but delayed by regulatory concerns.

Authors from GIMBHI and Columbia Psychiatry Mind Ventures write about the future of digital therapeutics.

MobiHealthNews editors share some highlights from last week's Apple Event, Digital Therapeutics East, and the Rock Health Summit.

Patient Orator CEO Kistein Monkhouse and Theator CEO Dr. Tamir Wolf discuss health disparities in the United States and how their companies are helping.

Pivot strategy, co-creating, sale cycles and quality control all need to be on the table when navigating today's chaotic healthcare market.

VR researcher and advocate Dr. Robert Louis gives HIMSS Media insight on the current state of VR in healthcare, and how the virus has impacted his hospital's rollout of the technology.  

Flare Capital Partners reviews the current landscape of substance use disorder treatment and highlights some early-stage tech companies tackling the ongoing opioid epidemic.

The past weeks have seen a wave of health tech companies pledging support to anti-racism protesters, as well as public pressure for clear action steps.

Healthbox President Neil Patel describes how his group is helping to facilitate the sharing of solutions and best practices around COVID-19 response.

Healthcare IT News Editor Mike Miliard, Healthcare Finance News Senior Editor Susan Morse and MobiHealthNews Associate Editor Dave Muoio delve into ONC's and CMS' new rules, how people are reacting and what might happen next.